In March 2023, national telehealth utilization rose 1.8%, up from 5.5% of medical claim lines in February, according to new data from FAIR Health’s Monthly Telehealth Regional Tracker.
National telehealth utilization increased 1.8% in March 2023, from 5.5% of medical claim lines in February to 5.6% in March, according to FAIR Health’s Monthly Telehealth Regional Tracker (FIGURE 1). The increase followed a decline in February 2023. In March, telehealth utilization also increased in 2 of the 4 US census regions—the Midwest (2.4%) and the West (2.6%). The other regions stayed level, with zero percent change in the Northeast and the South. The data represent the privately insured population, including Medicare Advantage and excluding Medicare fee-for-service and Medicaid.
Figure 1. Monthly Telehealth Regional Tracker, March 2023, United States
(Source: FAIR Health)
Top 5 Telehealth Diagnoses
The top 5 telehealth diagnoses remained the same in March 2023 as in February 2023 nationally and in the Midwest, Northeast and West. In the South, urinary tract infections entered the rankings in fifth place; hypertension rose from fifth place to third place; and encounter for examination, previously in third place, fell off the list entirely.
In March, mental health conditions, the top-ranking diagnosis nationally and in every region, rose from 66.7% of telehealth claim lines nationally in February to 67.4% in March—the third straight month of national increases.
The percentage of telehealth claim lines for the second-place diagnosis, acute respiratory diseases and infections, decreased nationally in March, falling from 3.5% in February to 3.2% in March. This was the third consecutive national monthly decrease for this diagnosis.
Asynchronous Telehealth
In March 2023, among the top 5 diagnoses via asynchronous telehealth, hypertension continued to rank second nationally and in the West, fourth in the South and first in the Midwest, as it had in February. In the Northeast, hypertension dropped from first place in February to second place in March and was replaced by mental health conditions, which moved up from second place in February to first in March (FIGURE 2).
(Source: FAIR Health)
In March, sleep disorders entered the rankings in the Northeast at number 5, replacing urinary tract infections. Sleep disorders increased in percentage of asynchronous telehealth claim lines in the Midwest, climbing from number 5 to number 4 in the rankings.
Audio-Only Telehealth Usage
In March 2023, utilization of audio-only telehealth services decreased in rural and urban areas in the Midwest. It also decreased in the Northeast and nationally but only in rural areas, while it stayed level in urban areas. By contrast, in the West, utilization decreased in urban areas but remained the same in rural areas. In the South, audio-only telehealth utilization increased in urban areas and remained level in rural areas.
Similar to February, utilization of audio-only telehealth services was generally higher in March in rural areas than urban areas, except in the South, where audio-only telehealth services accounted for 10.5% of telehealth claim lines in urban areas compared to 5.5% in rural areas.
Telehealth Cost Corner
For March 2023, the Telehealth Cost Corner spotlighted the cost of CPT 98960, education and training for patient self-management, each 30 minutes. Nationally, the median charge amount for this service when rendered via telehealth was $49.66, and the median allowed amount was $22.81.
For the Monthly Telehealth Regional Tracker, click here.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
2 Commerce Drive
Cranbury, NJ 08512